Clinical Trial Update: A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of bimatoprost in men with androgenetic alopecia (AGA) completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Alopecia, Alopecia, Androgenetic | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09